EUVIMEDEUVIMED entdecken
Crossref

CURRENT STATUS AND CHARACTERISTICS OF USE AND DISCARD IN BLOOD PRODUCTS FROM THE 2024 NATIONWIDE SURVEY ON TRANSFUSION MEDICINE

Akihiko Yokohama, Masashi Kon, Tomohiko Sato, Satoshi Yasumura, Shin-Ichiro Fujiwara, Yutaka Nagura, Junichi Kitazawa, Koji Yamamoto, Yuji Yonemura, Shigeyoshi Makino, Asashi Tanaka

Japanese Journal of Transfusion and Cell Therapy · 25.02.2026 · 72 (1) · 40-47

DOI: 10.3925/jjtc.72.40 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Transfusion and Cell Therapy, erschienen am 25.02.2026. Verfasst von Akihiko Yokohama und 10 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yokohama, A., Kon, M., Sato, T., Yasumura, S., Fujiwara, S., Nagura, Y., Kitazawa, J., Yamamoto, K., Yonemura, Y., Makino, S., & Tanaka, A. (2026). CURRENT STATUS AND CHARACTERISTICS OF USE AND DISCARD IN BLOOD PRODUCTS FROM THE 2024 NATIONWIDE SURVEY ON TRANSFUSION MEDICINE. Japanese Journal of Transfusion and Cell Therapy, 72(1), 40-47. https://doi.org/10.3925/jjtc.72.40

Vancouver

Yokohama A, Kon M, Sato T, Yasumura S, Fujiwara S, Nagura Y, et al. CURRENT STATUS AND CHARACTERISTICS OF USE AND DISCARD IN BLOOD PRODUCTS FROM THE 2024 NATIONWIDE SURVEY ON TRANSFUSION MEDICINE. Japanese Journal of Transfusion and Cell Therapy. 2026;72(1):40-47. doi:10.3925/jjtc.72.40

BibTeX
@article{Yokohama2026,
  author = {Yokohama, Akihiko and Kon, Masashi and Sato, Tomohiko and Yasumura, Satoshi and Fujiwara, Shin-Ichiro and Nagura, Yutaka and Kitazawa, Junichi and Yamamoto, Koji and Yonemura, Yuji and Makino, Shigeyoshi and Tanaka, Asashi},
  title = {CURRENT STATUS AND CHARACTERISTICS OF USE AND DISCARD IN BLOOD PRODUCTS FROM THE 2024 NATIONWIDE SURVEY ON TRANSFUSION MEDICINE},
  journal = {Japanese Journal of Transfusion and Cell Therapy},
  year = {2026},
  volume = {72},
  number = {1},
  pages = {40--47},
  doi = {10.3925/jjtc.72.40}
}
Kostenlos starten →